![Andrew Hedin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Hedin
Direktor/Vorstandsmitglied bei
Nido Biosciences, Inc.
Profil
Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.
Aktive Positionen von Andrew Hedin
| Unternehmen | Position | Beginn |
|---|---|---|
Deer Management Co. LLC
 Deer Management Co. LLC Investment ManagersFinance Bessemer Venture Partners invests in companies located across the globe. The firm focuses on broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size ranging from USD 30 - 125 million. | Private Equity Investor | 01.07.2015 |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Develops and manufactures biological precision medicines for neurological diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andrew Hedin
| Unternehmen | Position | Ende |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.06.2021 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm targets companies operating in life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private-Equity-Analyst | 30.07.2013 |
| TSCAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Ausbildung von Andrew Hedin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
34
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Deer Management Co. LLC
Deer Management Co. LLC Investment ManagersFinance Bessemer Venture Partners invests in companies located across the globe. The firm focuses on broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size ranging from USD 30 - 125 million. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm targets companies operating in life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Develops and manufactures biological precision medicines for neurological diseases | Health Technology |
